| European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus group (EGCCCG): part I S Krege, J Beyer, R Souchon, P Albers, W Albrecht, F Algaba, M Bamberg, ... European urology 53 (3), 478-496, 2008 | 764 | 2008 |
| Guidelines on testicular cancer: 2015 update P Albers, W Albrecht, F Algaba, C Bokemeyer, G Cohn-Cedermark, ... European urology 68 (6), 1054-1068, 2015 | 695 | 2015 |
| European consensus on diagnosis and treatment of germ cell cancer: a report of the European Germ Cell Cancer Consensus Group (EGCCCG) HJ Schmoll, R Souchon, S Krege, P Albers, J Beyer, C Kollmannsberger, ... Annals of Oncology 15 (9), 1377-1399, 2004 | 661 | 2004 |
| EAU guidelines on testicular cancer: 2011 update P Albers, W Albrecht, F Algaba, C Bokemeyer, G Cohn-Cedermark, ... European urology 60 (2), 304-319, 2011 | 463 | 2011 |
| Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancer J Beyer, P Albers, R Altena, J Aparicio, C Bokemeyer, J Busch, ... Annals of oncology 24 (4), 878-888, 2013 | 320 | 2013 |
| ESMO Consensus Conference on testicular germ cell cancer: diagnosis, treatment and follow-up F Honecker, J Aparicio, D Berney, J Beyer, C Bokemeyer, R Cathomas, ... Annals of oncology 29 (8), 1658-1686, 2018 | 300 | 2018 |
| Targeted prostate cancer screening in BRCA1 and BRCA2 mutation carriers: results from the initial screening round of the IMPACT study EK Bancroft, EC Page, E Castro, H Lilja, A Vickers, D Sjoberg, M Assel, ... European urology 66 (3), 489-499, 2014 | 290 | 2014 |
| Interim results from the IMPACT study: evidence for prostate-specific antigen screening in BRCA2 mutation carriers EC Page, EK Bancroft, MN Brook, M Assel, MH Al Battat, S Thomas, ... European urology 76 (6), 831-842, 2019 | 209 | 2019 |
| EAU guidelines on testicular cancer MP Laguna, G Pizzocaro, O Klepp, F Algaba, L Kisbenedek, O Leiva European urology 40 (2), 102-110, 2001 | 185 | 2001 |
| Taxanes in combination with cisplatin and fluorouracil for advanced penile cancer: preliminary results G Pizzocaro, N Nicolai, A Milani European urology 55 (3), 546-551, 2009 | 159 | 2009 |
| Peniscopically controlled CO2 laser excision for conservative treatment of in situ and T1 penile carcinoma: report on 224 patients G Bandieramonte, M Colecchia, L Mariani, SL Vullo, G Pizzocaro, L Piva, ... European urology 54 (4), 875-884, 2008 | 145 | 2008 |
| Pazopanib in advanced and platinum-resistant urothelial cancer: an open-label, single group, phase 2 trial A Necchi, L Mariani, N Zaffaroni, LH Schwartz, P Giannatempo, F Crippa, ... The lancet oncology 13 (8), 810-816, 2012 | 144 | 2012 |
| Targeted prostate cancer screening in men with mutations in BRCA1 and BRCA2 detects aggressive prostate cancer: preliminary analysis of the results of the … AV Mitra, EK Bancroft, Y Barbachano, EC Page, CS Foster, C Jameson, ... BJU international 107 (1), 28-39, 2011 | 129 | 2011 |
| A surveillance study of clinical stage I nonseminomatous germ cell tumors of the testis: 10-year followup N Nicolai, G Pizzocaro The Journal of urology 154 (3), 1045-1049, 1995 | 129 | 1995 |
| Survival of male genital cancers (prostate, testis and penis) in Europe 1999–2007: Results from the EUROCARE-5 study A Trama, R Foschi, N Larrañaga, M Sant, R Fuentes-Raspall, D Serraino, ... European Journal of Cancer 51 (15), 2206-2216, 2015 | 117 | 2015 |
| Predictors of health-related quality of life and adjustment to prostate cancer during active surveillance L Bellardita, T Rancati, MF Alvisi, D Villani, T Magnani, C Marenghi, ... European urology 64 (1), 30-36, 2013 | 107 | 2013 |
| Testicular tumour size and rete testis invasion as prognostic factors for the risk of relapse of clinical stage I seminoma testis patients under surveillance: a systematic … JL Boormans, JM de Castro, L Marconi, Y Yuan, MPL Pes, C Bokemeyer, ... European urology 73 (3), 394-405, 2018 | 101 | 2018 |
| Radiotherapy or chemotherapy for clinical stage IIA and IIB seminoma: a systematic review and meta-analysis of patient outcomes P Giannatempo, T Greco, L Mariani, N Nicolai, S Tana, E Farè, D Raggi, ... Annals of Oncology 26 (4), 657-668, 2015 | 94 | 2015 |
| Adjuvant chemotherapy is associated with improved overall survival in pelvic node–positive penile cancer after lymph node dissection: a multi-institutional study P Sharma, R Djajadiningrat, K Zargar-Shoshtari, M Catanzaro, Y Zhu, ... Urologic Oncology: Seminars and Original Investigations 33 (11), 496. e17 …, 2015 | 91 | 2015 |
| The relationship between characteristics of inguinal lymph nodes and pelvic lymph node involvement in penile squamous cell carcinoma: a single institution experience G Lughezzani, M Catanzaro, T Torelli, L Piva, D Biasoni, S Stagni, ... The Journal of urology 191 (4), 977-982, 2014 | 87 | 2014 |
